Apple defeats bid for new Apple Watch import ban at US trade tribunal

Apr 18, 2026

1 minute read

The U.S. International Trade Commission ruled for Apple, declining to review a judge's March decision that Apple's redesigned Apple Watches do not infringe Masimo's blood-oxygen reading patents. This closes Masimo's bid to reinstate an import ban on Apple's Series 9 and Ultra 2 smartwatches. Masimo can appeal to the Federal Circuit. The companies remain in litigation over patent infringement and trade-secret theft, with Masimo winning $634 million in a separate November patent trial.

Read the full story on Indiatimes

Stay informed!

Subscribe to receive weekly litigation news updates. No spam.